BIOSTEM U.S. CORP: key financial figures for fiscal year 2011 (in USD), standardized from XBRL/iXBRL filings by Hub-Equity:
- Revenue (FY2011)
- $94.7K
- Net Income/Loss (FY2011)
- -$3.3M
- Total Assets (FY2011)
- $15.9K
- Total Equity (FY2011)
- -$74.4K
- Cash Flows from Operating Activities (FY2011)
- -$746.1K
Source: BIOSTEM U.S. CORP 10-K filing (FY2011). Full income statement, balance sheet and cash flow, restatement-aware and traceable to the source filing, at Hub-Equity.
